Evaxion Biotech A/S
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Evaxion Biotech A/S's balance sheet done over the years? Its assets were worth $12,889,000 last year, which is more than in the previous period. 137% of Evaxion Biotech A/S’s total assets is currently financed by debt. Its liabilities reached the amount of $17,618,000, which means an increase by 28% compared compared to last year.

Debt to Assets

Evaxion Biotech A/S (NASDAQ:EVAX): Debt to assets
2017 2949000 399K 13.53%
2018 8513000 9.44M 110.94%
2019 11084000 1.72M 15.54%
2020 11965000 4.92M 41.18%
2021 40163000 7.72M 19.24%
2022 -58937000 13.72M -23.28%
2023 12889000 17.61M 136.69%

EVAX Balance Sheet (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Assets
Current assets:
Cash and cash equivalents
5.58M13.18M32.16M5.83M9.55M7.43M468K
Short term investments
0000000
Net receivables
1.07M789K1.90M1.79M931K772K2.13M
Inventory
0-2.49M-1.90M-6.91M-6-1.36M0
Other current assets
1.69M2.49M2.53M5.11M468.00K178K133K
Total current assets
8.35M13.97M34.70M5.83M10.95M8.38M2.73M
Non-current assets:
Property, Plant and Equipment
4.34M4.67M5.36M457K126K130K213K
Goodwill
0000000
Intangible assets
0093K100K000
Long term investments
28.99K209.00K05.31M000
Other non-current assets
167.00K155.99K02K00-2K
Total non-current assets
4.53M5.04M5.45M6.13M126K130K211K
Total assets
12.88M-58.93M40.16M11.96M11.08M8.51M2.94M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0000000
Short term debt
485K303K440K20K36K8.64M66K
Total current liabilities
7.08M3.76M4.32M4.92M1.72M9.42M303K
Non-current liabilities:
Long term debt
10.38M1.95M3.25M0024K96K
Deferred tax
0000000
Other non-current liabilities
159K8.00M153K0000
Total non-current liabilities
10.54M9.96M3.40M0024K96K
Total liabilities
17.61M13.72M7.72M4.92M1.72M9.44M399K
Data sourceData sourceData sourceData source